Articles

A nurse-led initiative to discharge patients before noon has paid off at the Mount Sinai Hospital, NY, according to Kathleen Edmondson-Martin, MA, RN, OCN, Clinical Nurse Manager in the hospital's bone marrow transplant unit. Read More ›

Response is a poor outcome measure of immunotherapy, according to Tanguy Seiwert, MD, who addressed this and other concerning issues in immunotherapy at the 2016 Multidisciplinary Head and Neck Cancer Symposium. Read More ›

Cigarette smoking is associated with a wide variety of adverse health effects. Read More ›

Proper attention to dental care for patients with head and neck cancer can mean the difference between a good functional outcome and a poor one, according to a dental oncologist and nurse who described dental oncology at the Oncology Nursing Society 41st Annual Congress. Read More ›

An updated survivorship guideline from the National Comprehensive Cancer Network (NCCN) includes an extensive revision on addressing sexual function in cancer survivors. Read More ›

Although it is a rare disorder, approximately 14,000 new cases of sarcoma are diagnosed in the United States each year. Read More ›

CancerLinQ (Learning Intelligence Network for Quality) is a powerful database containing a vast amount of usable, searchable, real-world cancer information, created by oncologists, for oncologists, to improve the quality of patient care, according to updates presented at the 2016 American Society of Clinical Oncology (ASCO) Quality Care Symposium. Read More ›

Early intervention utilizing a team approach is important to successful palliative care, agreed a multidisciplinary panel convened at the National Comprehensive Cancer Network (NCCN) 21st Annual Conference. Read More ›

In this interview, members of The Urology Group discussed the importance of bone health in patients with prostate cancer, including details about the guidelines they use, the impact of prevention, as well as the different therapies they use in their practice. Read More ›

Head and neck lymphedema (HNL) is a common but underrecognized and poorly managed complication of treatment for head and neck cancer, but its accompanying functional impairments can be improved with targeted therapy, according to Jan S. Lewin, PhD. Read More ›